L9- Parkinson's Disease Treatment (others) Flashcards

1
Q

list the dopamine receptor agonists (indicate which type is used more and why)

A

Ergots: bromocriptine (D2 agonist)- not used b/c way more AEs

Nonergots: pramipexole, ropinirole, rotigotine (trans-dermal form)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the advantages of using dopamine agonists in comparison to levodopa

A
  • it does not require conversion by active dopamine neurons, so the functional capacity Nigrastriatal pathway is not a factor — works better for advanced PD
  • longer half-lives, dec dose frequency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

______ is a dopamine agonist that can be given by TD administration

A

rotigotine- nonergot dopamine agonist, used once a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

name and describe the use of Nonergot Dopamine Agonists

A

Pramipexole, Ropinirole:

  • increasing use as initial Tx (instead of levodopa adjunct)
  • important in younger Pts as older Pts are more vulnerable to cognitive AEs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dopamine Agonist AEs:

  • (1) GI
  • (2) CVS
A

1- anorexia, n/v, constipation, dyspepsia; bleeding from peptic ulceration

2- postural hypotension, cardiac arrhythmias, peripheral edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dopamine Agonist AEs: neurological

A
  • dyskinesia: abnormal movements
  • mental disturbances: confusion, hallucinations, delusions
  • dopamine dysregulation syndrome = impaired impulse control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dopamine Agonist AEs: miscellaneous by subtype

A

Ergots: HA, nasal congestion, inc arousal, pulmonary infiltrates, pleural / retroperitoneal fibrosis, erythromelalgia, painless digital vasospasm, cardiac valve fibrosis

Nonergots: uncontrollable somnolence (stop med if this occurs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

list the Dopamine agonist contraindications

A
  • psychosis
  • recent MI
  • PVD
  • PUD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Apomorphine:

  • (1) MOA
  • (2) explain how to avoid important AE
  • (3) other AEs
A

1- dopamine receptor antagonist

2- pretreat with Trimethobenzamide (anti-emetic) to prevent vomiting

3- QT prolongation, dyskinesia, drowsiness, sweating, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

______ are the inhibitors of dopamine metabolism

A
  • MAOIs

- COMT inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

list the useful MAOIs, explain MOA

A

**MOA: selective MAO-B inhibitors (MAO-B breakdown dopamine and tyramine) – [used as ADJUNCTs]

Selegiline: dec dopamine breakdown in brain –> enhances levodopa effects (allows for dec dose)

Rasagiline: enhances levodopa effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the main difference between Selegiline and Rasagiline

A

Both are MAO-B inhibitors

  • Selegiline –> metabolized to methamphetamine / amphetamine => insomnia, confusion in elderly
  • Rasagiline –> not metabolized to amphetamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

list the COMT inhibitors and why which are chosen over the others

A

Tolcapone:

  • preferred MOA b/c CNS and periphery
  • not preferred b/c causes fulminating hepatic necrosis
  • Entacapone:
  • only periphery MOA
  • *preferred b/c no AE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the main useful effects of COMT inhibitors

A
  • dec levodopa metabolism
  • dec plasma [3-O-methyldopa]
  • inc uptake levodopa
  • inc dopamine in the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(1) is the antiviral that has antiparkinsonian actions. (1) has a (2) MOA and is used specifically for (3) in PD.

A

1- amantidine
2- unclear MOA
3- levodopa-induced dyskinesias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the general effects of Amantidine in terms of PD

A
  • high doses inc release and dec reuptake of dopamine
  • upregulates D2 receptors
  • NMDA antagonist
17
Q

Amantidine:

  • (1) common neuro AEs + (2) at high doses
  • (3) common cardiac AE
  • (4) less common AE that clears w/in a month of drug withdrawal
A

1- restlestness, agitation, confusion, hallucinations
2- acute toxic psychosis

3- peripheral edema (responds to diuretics), used with caution for patients with h/o HF, seizures

4- Livedo Reticularis: mottled reticulated vascular pattern that appears as a lace-like purplish discoloration of the skin

18
Q

Amantidine:

  • (1) common neuro AEs + (2) at high doses
  • (3) common cardiac AE
  • (4) less common AE that clears w/in a month of drug withdrawal
A

1- restlestness, agitation, confusion, hallucinations
2- acute toxic psychosis

3- peripheral edema (responds to diuretics), used with caution for patients with h/o HF, seizures

4- Livedo Reticularis: mottled reticulated vascular pattern that appears as a lace-like purplish discoloration of the skin

19
Q

list the Antimuscarinics used to help treat PD + include MOA

A

(tertiary amines)

  • benzotropine
  • trihexylphenidyl

-inhibits excitatory cholinergic interneurons in Striatum

20
Q

what are the effects of antimuscarinics in PD

A
  • adjuvant therapy
  • to improve tremor and rigidity
  • little effect on bradykinesia
21
Q

Antimuscarinic AEs (in PD)

A

mood changes, confusion, hallucinations
xerostomia, pupillary dilation
urinary retention

22
Q

Antimuscarinic contraindication (in PD)

A

glaucoma
BPH
pyloric stenosis